BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5252300)

  • 1. [On the tactics of myelosan therapy of chronic myeloleukosis].
    Kassirskiĭ IA; Volkova MA
    Ter Arkh; 1967 Feb; 39(2):3-9. PubMed ID: 5252300
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kinetic constants of leukocyte reduction in the course of treatment of chronic myeloleukosis with different doses of myelosan].
    Levitin EI; Kukharenko IuA; Evsenko LS; Emanuel' NM
    Izv Akad Nauk SSSR Biol; 1968; 5():739-43. PubMed ID: 5262634
    [No Abstract]   [Full Text] [Related]  

  • 3. [The development of aplasia of hematopoiesis after the use of myelosan in patients with chronic myeloleukosis].
    Klimova NF; Cherntsova TA; Protasova TG
    Sov Med; 1967 Dec; 30(12):67-71. PubMed ID: 5250006
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic myelogenous leukemia. Results of therapy with busulfan].
    Olesen J; Videbaek A
    Nord Med; 1969 Oct; 82(41):1284-90. PubMed ID: 5260856
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myelosan (1,4-dimethanesulfoniloxybutane) and its significance in the therapy of chronic myeloleukosis].
    CHERNOV VA
    Klin Med (Mosk); 1958 Jul; 36(7):73-82. PubMed ID: 13576704
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ambulatory treatment of patients with chronic myeloid leukemia].
    Lobanova NA
    Ter Arkh; 1981; 53(9):25-8. PubMed ID: 6946602
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pregnancy during busulfan therapy of chronic granulocytic leukemia].
    Szentcsíki M; Brenner F; Balogh C; Hites L
    Orv Hetil; 1982 May; 123(21):1307-8. PubMed ID: 6955735
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of chronic myeloleukosis with myelosan.
    PAVLOVSKAIA NI
    Klin Med (Mosk); 1958 Jul; 36(7):82-8. PubMed ID: 13576705
    [No Abstract]   [Full Text] [Related]  

  • 9. Method of treatment of chronic myeloleukosis with myelosan.
    MOKEEVA RA
    Klin Med (Mosk); 1958 Jul; 36(7):89-93. PubMed ID: 13576706
    [No Abstract]   [Full Text] [Related]  

  • 10. The possibility of radical chemotherapy in chronic myelocytic leukaemia.
    Galton DA
    Haematol Lat; 1969; 12(3):703-9. PubMed ID: 5273182
    [No Abstract]   [Full Text] [Related]  

  • 11. [Continual and periodic treatment of patients with chronic granulocytic leukemia].
    Colović M; Petrović M; Jancić MS; Banićević B; Vucić Lj; Janosević S; Ristić M
    Srp Arh Celok Lek; 1984 Apr; 112(4):487-93. PubMed ID: 6595809
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of the kinetic method for evaluation of the effectiveness of treating chronic leukemia patients with myelosan and degranol and their effect on the hemogram].
    Bala IuM; Rosnovskiĭ VS; Biriukova IV
    Probl Gematol Pereliv Krovi; 1971 May; 16(5):14-6. PubMed ID: 5292230
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro drug sensitivity studies of CFUc in chronic myelocytic leukemia: I. Suicide indices and busulfan sensitivity determinations during the chronic phase.
    Preisler HD; Kirshner J
    Exp Hematol; 1983 Aug; 11(7):618-25. PubMed ID: 6576910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
    Larrain C; Cruz A; Codoceo V
    Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of 100 cases of chronic myeloid leukemia with Myleran.
    Pawelski S; Topolska P; Rechowicz K; Krzyzanowska-Wozniakowska
    Pol Med Sci Hist Bull; 1968 Jul; 11(3):101-4. PubMed ID: 5243952
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic myelosis treatment with Myleran (Myelosan).
    Atanasov K; Baltov I; Kirova V; Vakrilov V; Tzvetkova T
    Folia Med (Plovdiv); 1978; 20(1):54-8. PubMed ID: 104910
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serious hematological accidents due to Myleran in the treatment of chronic myeloid leukemia].
    Olmer J; Muratore R; Gabriel B; Canu AM
    Mars Med; 1968; 105(4):330-8. PubMed ID: 5245481
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation.
    Ferrara F; Palmieri S; Annunziata M; Viola A; Pocali B; Califano C; D'Arco AM; Mele G
    Bone Marrow Transplant; 2004 Oct; 34(7):573-6. PubMed ID: 15258559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myelobromol treatment of patients with chronic myeloleukosis].
    Cherntsova TA; Klimova NF; Susoeva VM
    Klin Med (Mosk); 1967 Jul; 45(7):96-104. PubMed ID: 5250315
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination chemotherapy for chronic granulocytic leukaemia.
    Resegotti L; Dolci C
    Haematologica; 1981 Oct; 66(5):709-10. PubMed ID: 6796479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.